Catabasis begins phase II trial of CAT-2003 in hypertriglyceridemia and hypercholesterolemia Aug. 22, 2013
Uncovering a causative link between endocannabinoid-mediated inflammation and type 2 diabetes Aug. 22, 2013
RSS